Innovent Biologics Inc. (IVBXF)
PNK: IVBXF
· Real-Time Price · USD
5.97
0.00 (0.00%)
At close: Apr 29, 2025, 8:00 PM
Innovent Biologics Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
Fiscal Year | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 | Q4 2019 | Q2 2019 | Q4 2018 | Q2 2018 | Q4 2017 | Q2 2017 | Q4 2016 | Q2 2016 |
Period Ending | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
-392.62M | -888.76M | -139.15M | -1.23B | -950.47M | -1.73B | -1B | -390.23M | -608.19M | -1.01B | -714.41M | -5.82B | 43.89M | -355.36M | -206.96M | -272.23M | -272.23M | |
198.67M | 183.14M | 187.62M | 151.85M | 124.93M | 112.66M | 89.51M | 29.2M | 56.43M | 47.47M | 38.9M | 32.32M | 30.49M | 30.75M | 29.1M | 27.3M | 27.3M | |
297.72M | 347.21M | 226.99M | 208.31M | 261.18M | 262.54M | 239.04M | 247.84M | 154.66M | 106.3M | 46.77M | 11.46M | 41.98M | 21.42M | 7.88M | 4.25M | 4.25M | |
-25.21M | 575.82M | -9.05M | -402.53M | 89.08M | 769.8M | 94.67M | 349.42M | -238.18M | 313.67M | -84.54M | 317.96M | 34.35M | 84.98M | -47.16M | 4.56M | 4.56M | |
-200.28M | 301.1M | -565.43M | -490.97M | 30.87M | -215.95M | 487.96M | 497.93M | 130.2M | -12.73M | 134.65M | 4.81B | -498.44M | -5.83M | -29.99M | 85.75M | 85.75M | |
n/a | n/a | 96.89M | -858.34M | 101.11M | n/a | 822.5M | 59.86M | 91.99M | 101.81M | 331M | 10.99M | -55.92M | -1.43M | -8.07M | -20.63M | -20.63M | |
-119.13M | 828.01M | -332.93M | 247.5M | -273.21M | 556.54M | -828.39M | 51.18M | -476.7M | 116.4M | -422.28M | 296.85M | 39.56M | 64.76M | -48.03M | -5.94M | -5.94M | |
-215.63M | 770.7M | -622.89M | -1.11B | -806.7M | -1.01B | -1.02B | 435.92M | -743.61M | -748.1M | -916.37M | -669.3M | -342.52M | -244.27M | -248M | -181.5M | -181.5M | |
-699.51M | -521.48M | -597.9M | -467.9M | -428.99M | -717.31M | -348.32M | -454.9M | -34.12M | -225.89M | -139.98M | -219.27M | -93.47M | -86.28M | -4.7M | -29.22M | -29.22M | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 178.6M | n/a | n/a | 2.11M | 2.11M | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -408.5M | -408.5M | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 147.57M | 147.57M | |
145.82M | -1.2B | 1.32B | -1.35B | 808.4M | -1.76B | 131.3M | -3.78B | -913.84M | -22.14M | -2.18B | 549.44M | 439.93M | 245.72M | -504.21M | 2M | 2M | |
-553.69M | -1.72B | 725.04M | -1.81B | 379.41M | -2.48B | -217.02M | -4.24B | -947.96M | -248.03M | -2.32B | 330.17M | 525.05M | 159.45M | -508.9M | -286.04M | -286.04M | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500 | -500 | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
-260.81M | 2.34B | 244.69M | 2.67B | 223.72M | 499.71M | 4.5B | 2.73B | 2.19B | 2.12B | -11.82M | 3.31B | 1.12B | -2.46M | 91.86M | -13.3M | -13.3M | |
-260.81M | 2.34B | 244.69M | 2.67B | 223.72M | 499.71M | 4.5B | 2.73B | 2.19B | 2.12B | -11.82M | 3.31B | 1.12B | -2.46M | 91.86M | 819.8M | 819.8M | |
-515.87M | 706.71M | 158.05M | -167.94M | -3.68M | -1.55B | 1.01B | -846.19M | 9.88M | 572.02M | -2.02B | 1.5B | 516.06M | -53.95M | -430.69M | 726.92M | 726.92M | |
-915.15M | 249.22M | -1.22B | -1.58B | -1.24B | -1.73B | -1.36B | -18.98M | -777.73M | -973.99M | -1.06B | -888.57M | -436M | -330.54M | -252.7M | -210.72M | -210.72M |